{"transactions":[{"id":707733,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2026-07-18T01:50:16.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":78700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant."}],"balance_after":78700,"derivative":{"exercise_price":0.5149,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":78700},"source":{"system":"sec-edgar","filing":"0001437749-26-023808","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926023808/rdgdoc.xml","form_type":"4"}},{"id":707732,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-18T01:50:16.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":39400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant."}],"balance_after":173525,"source":{"system":"sec-edgar","filing":"0001437749-26-023808","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926023808/rdgdoc.xml","form_type":"4"}},{"id":765062,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-26T21:11:11.000Z","date":"2026-05-22","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.653,"value":6530.0,"ownership":{"direct":true},"balance_after":134125,"source":{"system":"sec-edgar","filing":"0001437749-26-018385","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926018385/rdgdoc.xml","form_type":"4"}},{"id":979794,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-05T22:46:47.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.407,"value":2035.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 is being filed late due to delays in receiving EDGAR access codes."}],"balance_after":124125,"source":{"system":"sec-edgar","filing":"0001437749-25-037051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925037051/rdgdoc.xml","form_type":"4"}},{"id":979793,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-05T22:46:47.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.41,"value":6150.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 is being filed late due to delays in receiving EDGAR access codes."}],"balance_after":119125,"source":{"system":"sec-edgar","filing":"0001437749-25-037051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925037051/rdgdoc.xml","form_type":"4"}},{"id":1078802,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-01T00:38:50.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.405,"value":4050.0,"ownership":{"direct":true},"balance_after":104125,"source":{"system":"sec-edgar","filing":"0001437749-25-024250","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925024250/rdgdoc.xml","form_type":"4"}},{"id":1110641,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T01:05:24.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":95400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary of the date of the grant."}],"balance_after":95400,"derivative":{"exercise_price":0.7,"expiration_date":"2035-06-13","underlying":"Common Stock","underlying_shares":95400},"source":{"system":"sec-edgar","filing":"0001437749-25-020571","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925020571/rdgdoc.xml","form_type":"4"}},{"id":1110640,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T01:05:24.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary date of the grant."}],"balance_after":94125,"source":{"system":"sec-edgar","filing":"0001437749-25-020571","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925020571/rdgdoc.xml","form_type":"4"}},{"id":1474178,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-20T10:10:10.000Z","date":"2024-06-18","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.6789,"value":13578.0,"ownership":{"direct":true},"balance_after":78125,"source":{"system":"sec-edgar","filing":"0001437749-24-020694","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924020694/rdgdoc.xml","form_type":"4"}},{"id":1482724,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-12T20:39:15.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":95400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary of the date of the grant."}],"balance_after":95400,"derivative":{"exercise_price":0.77,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":95400},"source":{"system":"sec-edgar","filing":"0001437749-24-020095","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924020095/rdgdoc.xml","form_type":"4"}},{"id":1482723,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-12T20:39:15.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary date of the grant."}],"balance_after":58125,"source":{"system":"sec-edgar","filing":"0001437749-24-020095","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924020095/rdgdoc.xml","form_type":"4"}},{"id":1820097,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-08-02T01:23:32.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":44224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary of the date of the grant."}],"balance_after":44224,"derivative":{"exercise_price":0.74,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":44224},"source":{"system":"sec-edgar","filing":"0001437749-23-021507","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923021507/rdgdoc.xml","form_type":"4"}},{"id":1820096,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-02T01:23:32.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":7375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary date of the grant."}],"balance_after":42125,"source":{"system":"sec-edgar","filing":"0001437749-23-021507","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923021507/rdgdoc.xml","form_type":"4"}},{"id":2075874,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-28T22:25:15.000Z","date":"2022-12-28","kind":"purchase","acquired":true,"shares":20000,"price":0.757,"value":15140.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-22-029843","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922029843/rdgdoc.xml","form_type":"4"}},{"id":2192775,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-08-08T22:39:08.000Z","date":"2022-08-04","kind":"grant","acquired":true,"shares":88448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest annually over three years from the vesting commencement date of August 4, 2022, the date of the grantee's appointment as a director of Vaxart, Inc."}],"balance_after":88448,"derivative":{"exercise_price":3.91,"expiration_date":"2032-08-03","underlying":"Common Stock","underlying_shares":88448},"source":{"system":"sec-edgar","filing":"0001437749-22-019446","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922019446/rdgdoc.xml","form_type":"4"}},{"id":2192774,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-08-08T22:39:08.000Z","date":"2022-08-04","kind":"grant","acquired":true,"shares":14750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. One third of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the third anniversary of the grant date."}],"balance_after":14750,"source":{"system":"sec-edgar","filing":"0001437749-22-019446","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922019446/rdgdoc.xml","form_type":"4"}},{"id":2321967,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:18:46.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":85760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":3.66,"underlying":"Common Stock","underlying_shares":85760},"source":{"system":"sec-edgar","filing":"0001103021-22-000075","document":"wf-form4_164798391255661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000075/wf-form4_164798391255661.xml","form_type":"4"}},{"id":2321966,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:18:46.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":54740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":2.93,"underlying":"Common Stock","underlying_shares":54740},"source":{"system":"sec-edgar","filing":"0001103021-22-000075","document":"wf-form4_164798391255661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000075/wf-form4_164798391255661.xml","form_type":"4"}},{"id":2321965,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-03-22T17:18:46.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":22685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":22685},"source":{"system":"sec-edgar","filing":"0001103021-22-000075","document":"wf-form4_164798391255661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000075/wf-form4_164798391255661.xml","form_type":"4"}},{"id":2321964,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T17:18:46.000Z","date":"2022-03-22","kind":"other","acquired":false,"shares":90663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 14, 2022, by and among the Issuer, Collegium Pharmaceutical, Inc., (\"Parent\"), and Bristol Acquisition Company Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of Issuer, $0.001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 22, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $5.60 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 14, 2022, by and among the Issuer, Collegium Pharmaceutical, Inc., (\"Parent\"), and Bristol Acquisition Company Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of Issuer, $0.001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 22, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $5.60 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 14, 2022, by and among the Issuer, Collegium Pharmaceutical, Inc., (\"Parent\"), and Bristol Acquisition Company Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of Issuer, $0.001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 22, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $5.60 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001103021-22-000075","document":"wf-form4_164798391255661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000075/wf-form4_164798391255661.xml","form_type":"4"}},{"id":2421456,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-31T18:06:38.000Z","date":"2022-01-27","kind":"exercise","acquired":false,"shares":7684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (\"the Plan\"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."}],"balance_after":7685,"derivative":{"exercise_price":0,"expiration_date":"2023-01-27","underlying":"Common Stock","underlying_shares":7684},"source":{"system":"sec-edgar","filing":"0001103021-22-000025","document":"wf-form4_164367038088743.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000025/wf-form4_164367038088743.xml","form_type":"4"}},{"id":2421455,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-31T18:06:38.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":15369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (\"the Plan\"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (\"the Plan\"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."}],"balance_after":15369,"derivative":{"exercise_price":0,"expiration_date":"2023-01-27","underlying":"Common Stock","underlying_shares":15369},"source":{"system":"sec-edgar","filing":"0001103021-22-000025","document":"wf-form4_164367038088743.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000025/wf-form4_164367038088743.xml","form_type":"4"}},{"id":2421454,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-01-31T18:06:38.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":85760,"price":3.66,"value":313881.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The stock options were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Plan. The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Plan. The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."}],"balance_after":85760,"derivative":{"exercise_price":3.66,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":85760},"source":{"system":"sec-edgar","filing":"0001103021-22-000025","document":"wf-form4_164367038088743.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000025/wf-form4_164367038088743.xml","form_type":"4"}},{"id":2421453,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-31T18:06:38.000Z","date":"2022-01-27","kind":"exercise","acquired":true,"shares":7684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (\"the Plan\"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."}],"balance_after":90663,"source":{"system":"sec-edgar","filing":"0001103021-22-000025","document":"wf-form4_164367038088743.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000025/wf-form4_164367038088743.xml","form_type":"4"}},{"id":2588806,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-08-27T12:49:25.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":13491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sykes Enterprises, Incorporated (the \"Company) entered into an Agreement and Plan of Merger dated as of June 17, 2021 (the \"Merger Agreement\") by and among the Company, Sitel Worldwide Corporation, a Delaware corporation (\"Parent\") and Florida Mergersub, Inc., a Florida corporation and a wholly-owned subsidiary of Parent (\"Merger Sub\").  On August 27, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Parent.  Pursuant to the terms of the Merger Agreement, each share of Company common stock and restricted stock units that were outstanding as of the closing of the merger was converted into the right to receive an amount in cash equal to $54.00, without interest and is subject to any applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 11,409 shares of Common Stock and 2,082 restricted stock units held by the Reporting Person.  In connection with the closing of the transactions contemplated by the Merger Agreement, each share of Common Stock held by the Reporting Person and each share of Common Stock underlying a restricted stock unit subject to time-based vesting that was outstanding as of the closing of the merger was converted into the right of the Reporting Person to receive a cash payment of $54.00, without interest and subject to any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-024398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760221024398/form4.xml","form_type":"4"}},{"id":2608822,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-08-10T18:21:29.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":15000,"derivative":{"exercise_price":0,"expiration_date":"2022-08-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001103021-21-000074","document":"wf-form4_162863407322242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000074/wf-form4_162863407322242.xml","form_type":"4"}},{"id":2608821,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T18:21:29.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":82979,"source":{"system":"sec-edgar","filing":"0001103021-21-000074","document":"wf-form4_162863407322242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000074/wf-form4_162863407322242.xml","form_type":"4"}},{"id":2706292,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-19T09:31:11.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":694,"price":41.43,"value":28752.42,"ownership":{"direct":true},"balance_after":11409,"source":{"system":"sec-edgar","filing":"0001127602-21-017319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760221017319/form4.xml","form_type":"4"}},{"id":2844213,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-22T11:39:46.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":181,"price":41.93,"value":7589.33,"ownership":{"direct":true},"balance_after":10715,"source":{"system":"sec-edgar","filing":"0001127602-21-006885","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760221006885/form4.xml","form_type":"4"}},{"id":2860280,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-16T10:15:39.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":1000,"price":42.86,"value":42860.0,"ownership":{"direct":true},"balance_after":10534,"source":{"system":"sec-edgar","filing":"0001127602-21-005650","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760221005650/form4.xml","form_type":"4"}},{"id":2931729,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2020-12-28T21:30:32.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":1306452,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1306452,"derivative":{"exercise_price":0.031,"exercise_date":"2020-12-22","expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":1306452},"source":{"system":"sec-edgar","filing":"0000899243-20-035202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924320035202/doc4.xml","form_type":"4"}},{"id":2970203,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-23T09:02:59.000Z","date":"2020-11-23","kind":"grant","acquired":true,"shares":181,"price":37.9,"value":6859.9,"ownership":{"direct":true},"balance_after":9534,"source":{"system":"sec-edgar","filing":"0001127602-20-029784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760220029784/form4.xml","form_type":"4"}},{"id":2981890,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-13T09:42:18.000Z","date":"2020-11-13","kind":"grant","acquired":true,"shares":1000,"price":37.2,"value":37200.0,"ownership":{"direct":true},"balance_after":9353,"source":{"system":"sec-edgar","filing":"0001127602-20-028900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760220028900/form4.xml","form_type":"4"}},{"id":3049014,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-08-24T08:04:34.000Z","date":"2020-08-24","kind":"grant","acquired":true,"shares":181,"price":33.42,"value":6049.02,"ownership":{"direct":true},"balance_after":8353,"source":{"system":"sec-edgar","filing":"0001127602-20-024085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760220024085/form4.xml","form_type":"4"}},{"id":3052658,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T16:30:36.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":13000,"price":5.18,"value":67340.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On August 17, 2020, the Reporting Person sold an aggregate of 13,000 shares of the Issuer's Common Stock at a weighted average price of $5.18 per share. The highest sale price for the Common Stock was $5.21 per share and the lowest sale price was $5.17 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":52979,"source":{"system":"sec-edgar","filing":"0001103021-20-000138","document":"wf-form4_159786902244654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000138/wf-form4_159786902244654.xml","form_type":"4"}},{"id":3059110,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-08-13T09:56:28.000Z","date":"2020-08-13","kind":"grant","acquired":true,"shares":1000,"price":34.36,"value":34360.0,"ownership":{"direct":true},"balance_after":8172,"source":{"system":"sec-edgar","filing":"0001127602-20-023525","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760220023525/form4.xml","form_type":"4"}},{"id":3062260,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-08-11T16:51:57.000Z","date":"2020-08-07","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (ii) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":45000,"derivative":{"exercise_price":0,"expiration_date":"2022-08-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001103021-20-000123","document":"wf-form4_159717910450200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000123/wf-form4_159717910450200.xml","form_type":"4"}},{"id":3062259,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T16:51:57.000Z","date":"2020-08-07","kind":"exercise","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (ii) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":65979,"source":{"system":"sec-edgar","filing":"0001103021-20-000123","document":"wf-form4_159717910450200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000123/wf-form4_159717910450200.xml","form_type":"4"}},{"id":3137905,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-22T08:37:45.000Z","date":"2020-05-22","kind":"grant","acquired":true,"shares":181,"price":25.95,"value":4696.95,"ownership":{"direct":true},"balance_after":7172,"source":{"system":"sec-edgar","filing":"0001127602-20-017628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760220017628/form4.xml","form_type":"4"}},{"id":3151399,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-13T10:26:07.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":1000,"price":25,"value":25000.0,"ownership":{"direct":true},"balance_after":6991,"source":{"system":"sec-edgar","filing":"0001127602-20-016366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760220016366/form4.xml","form_type":"4"}},{"id":3192379,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-30T14:54:14.000Z","date":"2020-03-30","kind":"sale","acquired":false,"shares":3000,"price":26.1,"value":78300.0,"ownership":{"direct":true},"balance_after":5991,"source":{"system":"sec-edgar","filing":"0001127602-20-012135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760220012135/form4.xml","form_type":"4"}},{"id":3196751,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2020-03-24T13:00:23.000Z","date":"2020-03-20","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1500000,"derivative":{"exercise_price":0.05,"exercise_date":"2021-03-20","expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0000899243-20-009308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924320009308/doc4.xml","form_type":"4"}},{"id":3254118,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-24T09:49:42.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":181,"price":35.67,"value":6456.27,"ownership":{"direct":true},"balance_after":8991,"source":{"system":"sec-edgar","filing":"0001127602-20-007103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760220007103/form4.xml","form_type":"4"}},{"id":3257468,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-21T08:45:17.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":983,"price":35.95,"value":35338.85,"ownership":{"direct":true},"balance_after":8810,"source":{"system":"sec-edgar","filing":"0001127602-20-006808","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760220006808/form4.xml","form_type":"4"}},{"id":3282859,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-10T21:20:28.000Z","date":"2019-12-12","kind":"purchase","acquired":true,"shares":500,"price":0.0619,"value":30.95,"ownership":{"direct":true},"balance_after":1054100,"source":{"system":"sec-edgar","filing":"0000899243-20-003818","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924320003818/doc5.xml","form_type":"5"}},{"id":3361678,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-22T08:50:19.000Z","date":"2019-11-22","kind":"grant","acquired":true,"shares":181,"price":34.92,"value":6320.52,"ownership":{"direct":true},"balance_after":7827,"source":{"system":"sec-edgar","filing":"0001127602-19-033522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760219033522/form4.xml","form_type":"4"}},{"id":3363375,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-21T09:12:30.000Z","date":"2019-11-21","kind":"grant","acquired":true,"shares":984,"price":35.27,"value":34705.68,"ownership":{"direct":true},"balance_after":7646,"source":{"system":"sec-edgar","filing":"0001127602-19-033462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760219033462/form4.xml","form_type":"4"}},{"id":3431471,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-08-22T08:42:16.000Z","date":"2019-08-22","kind":"grant","acquired":true,"shares":181,"price":29.19,"value":5283.39,"ownership":{"direct":true},"balance_after":6662,"source":{"system":"sec-edgar","filing":"0001127602-19-027206","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760219027206/form4.xml","form_type":"4"}},{"id":3432385,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-08-21T12:11:31.000Z","date":"2019-08-21","kind":"grant","acquired":true,"shares":984,"price":28.89,"value":28427.76,"ownership":{"direct":true},"balance_after":6481,"source":{"system":"sec-edgar","filing":"0001127602-19-027138","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760219027138/form4.xml","form_type":"4"}},{"id":3437812,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-08-15T16:29:12.000Z","date":"2019-08-13","kind":"exercise","acquired":false,"shares":24739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (ii) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iii) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":74640,"derivative":{"exercise_price":0,"expiration_date":"2022-08-01","underlying":"Common Stock","underlying_shares":24739},"source":{"system":"sec-edgar","filing":"0001103021-19-000009","document":"wf-form4_156590093644021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302119000009/wf-form4_156590093644021.xml","form_type":"4"}},{"id":3437811,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T16:29:12.000Z","date":"2019-08-13","kind":"exercise","acquired":true,"shares":24739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (ii) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iii) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":35979,"source":{"system":"sec-edgar","filing":"0001103021-19-000009","document":"wf-form4_156590093644021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302119000009/wf-form4_156590093644021.xml","form_type":"4"}},{"id":3496073,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2019-06-10T22:27:08.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":0.073,"exercise_date":"2020-02-03","expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-016242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924319016242/doc4.xml","form_type":"4"}},{"id":3515785,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-22T09:41:33.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":180,"price":25.75,"value":4635.0,"ownership":{"direct":true},"balance_after":5497,"source":{"system":"sec-edgar","filing":"0001127602-19-019394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760219019394/form4.xml","form_type":"4"}},{"id":3517317,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-21T09:23:05.000Z","date":"2019-05-21","kind":"grant","acquired":true,"shares":984,"price":25.41,"value":25003.44,"ownership":{"direct":true},"balance_after":5317,"source":{"system":"sec-edgar","filing":"0001127602-19-019253","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760219019253/form4.xml","form_type":"4"}},{"id":3636713,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-02-25T10:08:38.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":904,"price":31.1,"value":28114.4,"ownership":{"direct":true},"balance_after":4333,"source":{"system":"sec-edgar","filing":"0001127602-19-007886","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760219007886/form4.xml","form_type":"4"}},{"id":3639752,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-02-22T09:17:04.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":180,"price":30.51,"value":5491.8,"ownership":{"direct":true},"balance_after":3429,"source":{"system":"sec-edgar","filing":"0001127602-19-007604","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760219007604/form4.xml","form_type":"4"}},{"id":3674988,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2019-02-06T00:54:44.000Z","date":"2019-02-03","kind":"grant","acquired":true,"shares":657895,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":657895,"derivative":{"exercise_price":0.076,"exercise_date":"2020-02-03","expiration_date":"2029-02-03","underlying":"Common Stock","underlying_shares":657895},"source":{"system":"sec-edgar","filing":"0000899243-19-002712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924319002712/doc4.xml","form_type":"4"}},{"id":3753163,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-26T10:26:44.000Z","date":"2018-11-23","kind":"grant","acquired":true,"shares":903,"price":26.82,"value":24218.46,"ownership":{"direct":true},"balance_after":3249,"source":{"system":"sec-edgar","filing":"0001127602-18-034235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760218034235/form4.xml","form_type":"4"}},{"id":3753162,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-26T10:11:53.000Z","date":"2018-11-22","kind":"grant","acquired":true,"shares":180,"price":26.82,"value":4827.6,"ownership":{"direct":true},"balance_after":2346,"source":{"system":"sec-edgar","filing":"0001127602-18-034233","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760218034233/form4.xml","form_type":"4"}},{"id":3835024,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-23T08:42:04.000Z","date":"2018-08-23","kind":"grant","acquired":true,"shares":903,"price":29.31,"value":26466.93,"ownership":{"direct":true},"balance_after":2166,"source":{"system":"sec-edgar","filing":"0001127602-18-026057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760218026057/form4.xml","form_type":"4"}},{"id":3836352,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-22T08:35:26.000Z","date":"2018-08-22","kind":"grant","acquired":true,"shares":180,"price":29.42,"value":5295.6,"ownership":{"direct":true},"balance_after":1263,"source":{"system":"sec-edgar","filing":"0001127602-18-025954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760218025954/form4.xml","form_type":"4"}},{"id":3842157,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-08-16T17:00:48.000Z","date":"2018-08-14","kind":"exercise","acquired":false,"shares":9740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 24,379 RSUs vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (ii) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iii) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iv) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 24,379 RSUs vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (ii) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iii) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iv) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":99379,"derivative":{"exercise_price":0,"expiration_date":"2022-08-01","underlying":"Common Stock","underlying_shares":9740},"source":{"system":"sec-edgar","filing":"0000899243-18-022575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924318022575/doc4.xml","form_type":"4"}},{"id":3842156,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-16T17:00:48.000Z","date":"2018-08-14","kind":"exercise","acquired":true,"shares":9740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 24,379 RSUs vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (ii) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iii) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iv) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 24,379 RSUs vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (ii) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iii) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iv) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":11240,"source":{"system":"sec-edgar","filing":"0000899243-18-022575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924318022575/doc4.xml","form_type":"4"}},{"id":3853618,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-08-03T17:36:08.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":54770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options (\"options\") were issued to the Reporting Person on August 1, 2018, as compensation for service on the Issuer's board of directors. The options vest as follows: (i) 4,870 options vest in the first open window following the filing of the Company's quarterly 10Q for June 30, 2018, (ii) 12,370 options vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (iii) 15,000 options vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iv) 15,000 options vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (v) 7,500 options vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":54770,"derivative":{"exercise_price":2.93,"expiration_date":"2028-08-01","underlying":"Common Stock","underlying_shares":54770},"source":{"system":"sec-edgar","filing":"0000899243-18-021411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924318021411/doc4.xml","form_type":"4"}},{"id":3853617,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-08-03T17:36:08.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":109479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on August 1, 2018, as compensation for service on the Issuer's board of directors. The RSUs vest as follows: (i) 9,740 RSUs vest in the first open window following the filing of the Company's quarterly 10Q for June 30, 2018, (ii) 24,379 RSUs vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (iii) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iv) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (v) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":109479,"derivative":{"exercise_price":0,"expiration_date":"2022-08-01","underlying":"Common Stock","underlying_shares":109479},"source":{"system":"sec-edgar","filing":"0000899243-18-021411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924318021411/doc4.xml","form_type":"4"}},{"id":3914511,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-30T11:28:45.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":903,"price":27.68,"value":24995.04,"ownership":{"direct":true},"balance_after":1083,"source":{"system":"sec-edgar","filing":"0001127602-18-019228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760218019228/form4.xml","form_type":"4"}},{"id":3917609,"issuer":{"id":135946,"kind":"organization","name":"SYKES ENTERPRISES INC","symbol":"SYKE"},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-25T12:36:36.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":180,"price":27.69,"value":4984.2,"ownership":{"direct":true},"balance_after":180,"source":{"system":"sec-edgar","filing":"0001127602-18-018938","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010612/000112760218018938/form4.xml","form_type":"4"}},{"id":3994949,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2018-03-15T21:01:40.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":76000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":76000,"derivative":{"exercise_price":0.2722,"exercise_date":"2018-03-13","expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":76000},"source":{"system":"sec-edgar","filing":"0000899243-18-007585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924318007585/doc4.xml","form_type":"4"}},{"id":3994948,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2018-03-15T21:01:40.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":253000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options were granted subject to the approval of the majority stockholder of the registrant pursuant to an agreement between the majority stockholder and the registrant. In the event that the majority stockholder does not approve the option grant, the options will be canceled."}],"balance_after":253000,"derivative":{"exercise_price":0.2722,"exercise_date":"2019-03-13","expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":253000},"source":{"system":"sec-edgar","filing":"0000899243-18-007585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924318007585/doc4.xml","form_type":"4"}},{"id":4391056,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-10T21:19:41.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were issued to the reporting person on July 1, 2016, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were issued to the reporting person on July 1, 2016, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-17-007154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007154/doc4.xml","form_type":"4"}},{"id":4391055,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-10T21:19:41.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were issued to the reporting person on August 14, 2015, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were issued to the reporting person on August 14, 2015, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000899243-17-007154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007154/doc4.xml","form_type":"4"}},{"id":4391054,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-10T21:19:41.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-17-007154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007154/doc4.xml","form_type":"4"}},{"id":4391053,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:19:41.000Z","date":"2017-03-08","kind":"tax_withholding","acquired":false,"shares":79200,"price":0.34,"value":26928.0,"ownership":{"direct":true},"balance_after":553600,"source":{"system":"sec-edgar","filing":"0000899243-17-007154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007154/doc4.xml","form_type":"4"}},{"id":4391052,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:19:41.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The RSUs were issued to the reporting person on July 1, 2016, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":632800,"source":{"system":"sec-edgar","filing":"0000899243-17-007154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007154/doc4.xml","form_type":"4"}},{"id":4391051,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:19:41.000Z","date":"2017-03-08","kind":"tax_withholding","acquired":false,"shares":158400,"price":0.34,"value":53856.0,"ownership":{"direct":true},"balance_after":432800,"source":{"system":"sec-edgar","filing":"0000899243-17-007154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007154/doc4.xml","form_type":"4"}},{"id":4391050,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:19:41.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were issued to the reporting person on August 14, 2015, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":591200,"source":{"system":"sec-edgar","filing":"0000899243-17-007154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007154/doc4.xml","form_type":"4"}},{"id":4391049,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:19:41.000Z","date":"2017-03-08","kind":"tax_withholding","acquired":false,"shares":118800,"price":0.34,"value":40392.0,"ownership":{"direct":true},"balance_after":191200,"source":{"system":"sec-edgar","filing":"0000899243-17-007154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007154/doc4.xml","form_type":"4"}},{"id":4391048,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":29982,"kind":"person","name":"Watson W. Mark","position":1,"cik":"0001612372","reported_name":"Watson W. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:19:41.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":310000,"source":{"system":"sec-edgar","filing":"0000899243-17-007154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007154/doc4.xml","form_type":"4"}}]}